This collaborative initiative aimed to provide recommendations on the use of polyclonal
antithymocyte globulin (ATG) or anti-T lymphocyte globulin (ATLG) for the prevention of graft …

Haematopoietic stem cell transplantation was proposed as a treatment strategy just over 60
years ago. Owing to great advances in the field, haematopoietic stem cell transplantation …

Specific protocols define eligibility, conditioning, donor selection, graft composition and
prophylaxis of graft vs. host disease for children and young adults undergoing hematopoietic …

Background Neutropenia may limit the use of valganciclovir treatment for cytomegalovirus
(CMV) infection following hematopoietic cell transplant (HCT). A phase 2 study indicated …

The growing pool of critically ill or immunocompromised patients leads to a constant
increase of life-threatening invasive infections by fungi such as Aspergillus spp., Candida …

While progress has been made in the treatment of both hematologic cancers and solid
tumors, chemorefractory or relapsed disease often portends a dismal prognosis, and …

Infection with adenoviruses is a common and significant complication in pediatric patients
after allogeneic hematopoietic stem cell transplantation. Treatment options with traditional …

Background Maintaining gastrointestinal (GI) microbiome diversity plays a key role during
allogeneic stem cell transplantation (ASCT), and loss of diversity correlates with acute GI …

Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of
optimization of conditioning regimens and prevention of short-term complications with …

Recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for
hematological diseases are at risk of severe disease and death from COVID-19. To …